• SPX
  • $5,770.08
  • 1 %
  • $57.39
  • DJI
  • $42,128.75
  • 0.8 %
  • $334.14
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,175.26
  • -0.11 %
  • -$8.98
  • IXIC
  • $18,410.76
  • 1.27 %
  • $230.77

Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?

By Yahoo! Finance   |   Sep 2, 2024 at 06:56 AM EST
Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?

Immunovant's fair value estimate is 19% higher than its analyst price target. Using a Discounted Cash Flow model, the intrinsic value of the company is calculated at US$8.5b, showing a 46% discount to the current share price.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.